DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Rustin GJS.
Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed.
Ann Oncol 2011;
22 (Suppl 8) viii45-viii48
DOI: 10.1093/annonc/mdr471.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.